Sino-Europe Anti-Cancer Summit 2024
Miércoles 15 de Mayo de 09:00 horas a 11:00 horas
Sino-Europe Anti-Cancer Summit 2024
Organizer：CACA
Co-organizer: eChinaHealth，COR2ED
- Date:
China Standard Time：15:30-17:30, Wednesday, May 15, 2024(Tentative)
Central European Time：09:30-11:30, Wednesday, May 15, 2024(Tentative)
- Venue: Zoom Webinars
- Language: Chinese and English simultaneous translation
Acceso
English Channel: http://live2.yilingcloud.com/cacameetingLive/live/10928
Chinese Chanel: http://live2.yilingcloud.com/cacameetingLive/live/10927
Introduction
Cancer is one of the leading causes of illness and death in the world, and as the population ages, the global burden of cancer will continue to increase. It is expected that total number of cancer patients worldwide will reach approximately 28 million, and 16.2 million deaths by 2040. Over 40% of cancer cases are attributed to preventable factors such as smoking bans, healthy eating, physical activity, etc. Basic research and innovative therapies are also changing patients' outcome. The future path to fighting cancer requires international cooperation and the promotion of scientific and technological innovation.
This summit will invite anti-cancer leaders of China and Europe to jointly explore basic research, share the latest achievements in clinical practice, and exchange ideas and perspectives on the treatment of cancer patients.
The “2023 Sino-Europe Anti-Cancer Summit” webinar was organized by CACA, eChinaHealth and COR2ED on May 18st, 2023. The speakers include Dr. René Bernards, President of European Association for Cancer Research (EACR), Dr. Daiming Fan, President of China Anti-Cancer Association (CACA), Dr. Matti S. Aapro, President of Sharing Progress in Cancer Care (SPCC), and Dr. Andreas Charalambous, President of European Cancer Organisation (ECO). There were 12.5 million people watched the webinar.
Agenda
Moderator
- Yihai Cao, Karolinska Institutet
09:30-09:35 Opening Remark
- Ying Wang, Vice President of China Anti-Cancer Association (CACA)
09:35-10:35 Keynote Speech
09:35-09:50
- Topic：Development of Holistic Integrative Management of Cancer in China
Prof. Daiming Fan, President of China Anti-Cancer Association (CACA)
09:50-10:05
- Topic：TBD
Prof.Florian SCOTTE,MSACC Chairman Designate，Gustave Roussy (TBD）
10:05-10:20
- Topic：A new anticancer paradigm by activation of thermogenic adipose tissue
Prof. Yihai Cao, Karolinska Institutet
10:20-10:35
- Topic：Status and Challenges of Cancer Prevention and Control in Europe, and future collaboration with China
Prof. Csaba Dégi, President of European Cancer Organisation (ECO)
10:35-11:25 Panel Discussion
Moderator：
- Yihai Cao, Karolinska Institutet
Panelists：
- Daiming Fan, President of China Anti-Cancer Association (CACA)
- Csaba Dégi, President of European Cancer Organisation (ECO)
- Ying Wang, Vice President of China Anti-Cancer Association (CACA)
Prof.Florian SCOTTE,MSACC Chairman Designate，Gustave Roussy (TBD）
11:25-11:30 Closing Remarks
Speakers’ BIO
Prof. Daiming Fan
President, China Anti-Cancer Association
Professor Daiming Fan is the member of Chinese Academy of Engineering, International member of the USA and French National Academy of Medicine, President of the China Anti-Cancer Association (CACA), President of the Asia Pacific Digestive Week Federation, Member of the Board of Directors of the Union for International Cancer Control (2018-2022), Past Vice President of the Chinese Academy of Engineering, Past President of Asia Pacific Association of Gastroenterology. Prof. Fan specialized in both clinical and basic research into digestive diseases, especially gastrointestinal cancers. He has obtained numerous prestigious awards for his outstanding achievements, including several National Science and Technology Progress Awards. He was the first awardee of the Prize “French National Academy of Medicine-Servier”, and received the 2019 Masters of the WGO Award. As editor-in-chief he has authored 158 gastroenterology and oncology books, published over 700 peer review articles on international journals and serves as editor for 15 international medical journals.
Prof. Csaba Dégi
President of European Cancer Organisation (ECO)
Dr. Csaba L. Dégi is a Full Professor with habilitation and a researcher at the Babeș-Bolyai University, Faculty of Sociology and Social Work in Cluj Napoca, Romania. He is a licensed principal social worker with a private practice. Dr. Dégi earned bachelor's and master's degrees in social work, as well as a PhD in medical psychology. He holds the distinction of being the first ombudsman at the Babeș-Bolyai University, a member of ENOHE.
Dr. Dégi is a leading figure in the field of psycho-oncology, having worked with cancer patients, professionals, and oncology institutions since 2001. He is the Executive Secretary of the International Psycho-Oncology Society (IPOS) and a past member of the Board of Directors. He is also the President of the European Cancer Organisation (ECO) in Brussels, advocating for psychosocial oncology care across Europe and beyond. He is highly recognized for his contributions to clinical care, education, research, and cancer policy. Dr. Dégi is also the founder and president of the Romanian Association for Services and Communication in Oncology (APSCO), a proud member of the IPOS Federation, and a collaborating partner of the Innovative Partnership for Action Against Cancer initiative in Europe.
In 2016, the Romanian Ministry of Health appointed him as a single member of the Committee for Social Work and Support in Oncology. He has been featured in various publications, including Cancer Letter, Cancer World, and Politico. He is a member of the Editorial Board for the Journal of Psychosocial Oncology Research and Practice. He has also developed a distress screening app and has a wealth of original publications to his name.
Prof. Yihai Cao
Karolinska Institutet
Yihai Cao is a professor in medicine at the Karolinska Institutet, Stockholm, Sweden. He is a member of Chinese Academy of Engineering, Academia Europaea, European Academy of Sciences and Arts, National Academy of Inventors (US), and American Institute of Medicine and Biological Engineering (AIMBE). Yihai Cao received his medical training at the Shandong Medical School and his Ph.D. at the Karolinska Institute. He received his postdoctoral training in Dr. Judah Folkman’s laboratory at the Harvard Medical School. Cao’s laboratory has focused their interests on studying angiogenesis in tumor growth, metastasis, and non-malignant diseases. Through mechanistic studies, he aims to define novel therapeutic targets and resolve clinically unmet needs of antiangiogenic cancer therapy by proposing new concepts and paradigms. His research interests include molecular mechanisms of pathological angiogenesis contributing to obesity, metabolic diseases, diabetic complications, cancer, metastasis, and cardiovascular diseases, with emphasis on clinical relevance and translational research. He received an honorary medical doctor degree (M.D.) from Copenhagen University, Denmark in 2006. He is a guest professor at the Linköping University, Sweden; a guest professor at the Leicester University, UK; an honorary professor at the Copenhagen University, Denmark; and an honorary professor at the Shinshu University Japan. He received the Fernström research prize, the Axel Hirsch Prize in medicine, and a distinguished professor award at the Karolinska Institutet. Dr. Cao received an ERC-advanced research grant award and the distinguished NOVO Nordisk-advanced grant award. He has published more than 290 research articles. The average impact factor (IF) of his publications > 15.19 per article. According to Google Scholar, his scientific articles have been cited for more than 45470 times. H-index = 107.
Prof. Ying Wang
Vice President, China Anti-Cancer Association (CACA)
Secretary General of Asian Oncology Society (AOS)
Prof. Ying Wang serves as Vice President of China Anti-Cancer Association (CACA), Secretary General of Asian Oncology Society (AOS) and Executive Associate Editor-in-Chief of Holistic Integrative Oncology (HIO). She use to be the Deputy Director of Tianjin Medical University Cancer Institute and Hospital from 1998 to 2014.
Prof.Wang has a long history of participation with CACA by serving as a member of board of director since 1997. From 2012 to 2022, she servers as the Secretary General of CACA; In 2022, she was elected as the Vice President of CACA.